Immunogenicity 469
Sample ID
None
Response
Negative
Tumor Type
Melanoma
Gene Symbol
PSMB7
Transcript ID
None
HLA INFO
A*23:01
TCR INFO
No TCR info found!
Full length protein sequence (277 aa)
MAAVS
1
VYAPP
6
VGGFS
11
FDNCR
16
RNAVL
21
EADFA
26
KRGYK
31
LPKVR
36
KTGTT
41
IAGVV
46
YKDGI
51
VLGAD
56
TRATE
61
GMVVA
66
DKNCS
71
KIHFI
76
SPNIY
81
CCGAG
86
TAADT
91
DMTTQ
96
LISSN
101
LELHS
106
LSTGR
111
LPRVV
116
TANRM
121
LKQML
126
FRYQG
131
YIGAA
136
LVLGG
141
VDVTG
146
PHLYS
151
IYPHG
156
STDKL
161
PYVTM
166
GSGSL
171
AAMAV
176
FEDKF
181
RPDME
186
EEEAK
191
NLVSE
196
AIAAG
201
IFNDL
206
GSGSN
211
IDLCV
216
ISKNK
221
LDFLR
226
PYTVP
231
NKKGT
236
RLGRY
241
RCEKG
246
TTAVL
251
TEKIT
256
PLEIE
261
VLEET
266
VQTMD
271
TS
276
Mutation Information
DNA mutation:
None
Peptide Range:
156 ~ 181
Mut AA position:
158 (3 in Wild Type peptide)
Alignment
Wild Type:
"---------IYPHGSTDKL-------
||.|||||||
Mutant:
DVTGPHLYSIYLHGSTDKLPYVTMGS"
Nature, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaGene Name (from Reference) PSMB7
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
peptide
T-cell
Source
PBMCs
APC
Type
autologous APCs
Assay
IFNg ELISPOT assay